Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes

Overview

Journal JAMA

Publisher American Medical Association

Specialty General Medicine

Date 2021 Jun 2

PMID 34077505

Citations 8

Authors

Monica E Peek

Celeste C Thomas

Affiliations

Soon will be listed here.

Citing Articles

Relationship between hemoglobin glycation index and risk of hypoglycemia in type 2 diabetes with time-in-range in target.

Lin B, Liu Z, Chen D, Yang Y, Yang D, Yan J World J Diabetes. 2024; 15(10):2058-2069.

PMID: 39493564 PMC: 11525731. DOI: 10.4239/wjd.v15.i10.2058.

Continuous Glucose Monitor: Reclaiming Type 2 Diabetes Self-efficacy and Mitigating Disparities.

Ni K, Tampe C, Sol K, Cervantes L, Pereira R J Endocr Soc. 2024; 8(8):bvae125.

PMID: 38974988 PMC: 11223994. DOI: 10.1210/jendso/bvae125.

Demographic Variables Associated With Diabetes Technology Awareness or Use in Adults With Type 2 Diabetes.

Ye Y, Acevedo Mendez B, Izard S, Myers A Diabetes Spectr. 2024; 37(1):60-64.

PMID: 38385093 PMC: 10877207. DOI: 10.2337/ds23-0013.

Experiences and Perceptions of Telehealth Visits in Diabetes Care During and After the COVID-19 Pandemic Among Adults With Type 2 Diabetes and Their Providers: Qualitative Study.

Sun C, Shenk Z, Renda S, Maruthur N, Zheng S, Perrin N JMIR Diabetes. 2023; 8:e44283.

PMID: 37463021 PMC: 10394605. DOI: 10.2196/44283.

Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology Settings.

Mayberry L, Guy C, Hendrickson C, McCoy A, Elasy T J Gen Intern Med. 2023; 38(11):2546-2552.

PMID: 37254011 PMC: 10228889. DOI: 10.1007/s11606-023-08222-3.

References

Martens T, Beck R, Bailey R, Ruedy K, Calhoun P, Peters A . Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial. JAMA. 2021; 325(22):2262-2272. PMC: 8173473. DOI: 10.1001/jama.2021.7444. View

Cuttriss N, Bouchonville M, Maahs D, Walker A . Tele-rounds and Case-Based Training: Project ECHO Telementoring Model Applied to Complex Diabetes Care. Pediatr Clin North Am. 2020; 67(4):759-772. DOI: 10.1016/j.pcl.2020.04.017. View

Ida S, Kaneko R, Murata K . Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2019; 2019:4684815. PMC: 6350576. DOI: 10.1155/2019/4684815. View

Karter A, Parker M, Moffet H, Gilliam L, Dlott R . Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes. JAMA. 2021; 325(22):2273-2284. PMC: 8173463. DOI: 10.1001/jama.2021.6530. View

Beck R, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S . Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. JAMA. 2017; 317(4):371-378. DOI: 10.1001/jama.2016.19975. View

Bergenstal R, Layne J, Zisser H, Gabbay R, Barleen N, Lee A . Remote Application and Use of Real-Time Continuous Glucose Monitoring by Adults with Type 2 Diabetes in a Virtual Diabetes Clinic. Diabetes Technol Ther. 2020; 23(2):128-132. PMC: 7868574. DOI: 10.1089/dia.2020.0396. View

Spanakis E, Golden S . Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep. 2013; 13(6):814-23. PMC: 3830901. DOI: 10.1007/s11892-013-0421-9. View

Anderson J, Gavin J, Kruger D . Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified. Diabetes Technol Ther. 2019; 22(3):169-173. PMC: 7047118. DOI: 10.1089/dia.2019.0303. View

Selvin E, Parrinello C, Daya N, Bergenstal R . Trends in Insulin Use and Diabetes Control in the U.S.: 1988-1994 and 1999-2012. Diabetes Care. 2016; 39(3):e33-5. PMC: 4764038. DOI: 10.2337/dc15-2229. View

10.

Dicembrini I, Mannucci E, Monami M, Pala L . Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion. Diabetes Obes Metab. 2019; 21(12):2619-2625. DOI: 10.1111/dom.13845. View

11.

Peek M, Harmon S, Scott S, Eder M, Roberson T, Tang H . Culturally tailoring patient education and communication skills training to empower African-Americans with diabetes. Transl Behav Med. 2013; 2(3):296-308. PMC: 3717912. DOI: 10.1007/s13142-012-0125-8. View

12.

Galindo R, Parkin C, Aleppo G, Carlson A, Kruger D, Levy C . What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring. Diabetes Technol Ther. 2021; 23(9):652-660. PMC: 8501458. DOI: 10.1089/dia.2021.0107. View

13.

Ruedy K, Parkin C, Riddlesworth T, Graham C . Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial. J Diabetes Sci Technol. 2017; 11(6):1138-1146. PMC: 5951040. DOI: 10.1177/1932296817704445. View

14.

Wan W, Skandari M, Minc A, Nathan A, Winn A, Zarei P . Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. Diabetes Care. 2018; 41(6):1227-1234. PMC: 5961392. DOI: 10.2337/dc17-1821. View

15.

. 7. Diabetes Technology: . Diabetes Care. 2020; 44(Suppl 1):S85-S99. DOI: 10.2337/dc21-S007. View